
Jiang Xiaofeng
@j1ang_xia0feng
ID: 1703486426
27-08-2013 02:06:15
35 Tweet
17 Followers
66 Following

Happy to share our latest paper: Transformers can predict clinical outcome directly from MRI in #rectal #cancer 🤖🤩🏥 we are extending weakly supervised deep learning approaches from pathology to radiology with Daniel Truhn Else Kröner Fresenius Center for Digital Health @Medizin_TUD DKFZ Nationales Centrum für Tumorerkrankungen Dresden NCT Heidelberg


Looking forward to speaking at Memorial Sloan Kettering Cancer Center in October 2023 🤩🤩 together with amazing faculty FabriceAndre Ignacio Melero & many others Else Kröner Fresenius Center for Digital Health NCT Heidelberg Nationales Centrum für Tumorerkrankungen Dresden TU Dresden Gustave Roussy #TumourLandscape23

In the phase 3 GLOW trial, CAPOX plus zolbetuximab significantly improved progression free survival and overall survival in patients with CLDN18.2+, HER2- untreated #GastricCancer or gastroesophageal junction adenocarcinoma Astellas Pharma US Manish A. Shah nature.com/articles/s4159…




Today we are hosting „#AI in #medicine“ by Else Kröner Fresenius Center for Digital Health and Sächsische Staatskanzlei at @Medizin_TUD TU Dresden Nationales Centrum für Tumorerkrankungen Dresden DKFZ 🏥📺🩺 👉 discussing AI in healthcare 👉 research presentations 👉 locally developed AI products We are an AI hotspot and we have big plans for the future 🌳


NEW Research: "End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study ". #ColorectalCancer #DeepLearning Jakob Nikolas Kather Jiang Xiaofeng Else Kröner Fresenius Center for Digital Health DKFZ TU Dresden Nationales Centrum für Tumorerkrankungen Dresden NCT Heidelberg Read it here: buff.ly/41squ1n


Happy to share our latest preprint led by Omar S.M. El Nahhas 🌟: A manual for our deep learning pipeline for pathology image analysis, tried and tested in dozens of projects, fully open source. TU Dresden @nct_hd Nationales Centrum für Tumorerkrankungen Dresden @Medizin_TUD arxiv.org/abs/2312.10944


Welcome new Precision Medicine and Biomarkers Senior Editor Jakob Nikolas Kather, MD, who brings cutting-edge expertise in clinical AI applications—a new horizon in #precisionmedicine and clinical management of cancer. bit.ly/4b72V2F



Happy to share our new comment in Nature Reviews Cancer on guardrails for the use of generalist medical AI (GMAI) in oncology; with my brilliant colleague Stephen Gilbert from TU Dresden @Medizin_TUD. We discuss key regulatory challenges & propose physician-centric approaches to




